- Thesis: Role of Type I Interferon in Tumor Progression and Immune Cell Function.
- Scholarships: JN Tata Endowment Scholarship; Tata Education and Development Trust Scholarship.
- Relevant coursework: Cell Biology, Biochemistry, Tissue Engineering, Business in Biotechnology, Mathematical Methods in Bioengineering.
Deepakshi Kasat
San Diego, CA dkasat@ucsd.edu LinkedIn Google Scholar deepakshikasat.com
Summary
Scientific AI and data lead with experience across predictive modeling, automated scientific workflows, high-throughput screening, and enterprise AI strategy in oligonucleotide drug discovery. Appointed AI Champion for 300+ scientists in a 3,000+ person R&D organization. Built toxicity prediction models that enabled in silico discovery of novel sequences validated in vitro and progressing toward clinical trials. Designed automated hit-picking platforms that reduced processing from days to minutes across multiple therapeutic targets. Bridge between wet-lab biology, machine learning, data infrastructure, and business goals.
Education
- Ranked 2nd in the department; Branch Ambassador Award; Placement Envoy Award.
Core Competencies
AI/ML and Computational Biology: Predictive toxicity modeling (TLR8, ASO safety), automated hit-picking, AI agent development, Python, pandas, NumPy, scikit-learn, XGBoost, matplotlib, seaborn, feature engineering, model validation, reproducible pipelines, FAIR data principles, statistical inference.
AI Strategy and Leadership: AI Champion for 300+ scientists, AI Task Force leadership, enterprise AI adoption, use case packaging and scaling, responsible AI governance, scientist training and enablement, cross-functional alignment.
Automation and High-Throughput Screening: Automated liquid handling (Tecan Fluent, Hamilton STAR, Echo, Integra), multi-liability hit-picking, plate-based screening, dose-response workflows, operator guides, troubleshooting systems, Benchling and Labguru.
Assay Development and Biology: High-throughput NGS and cell-based assays, flow cytometry, ELISA, western blotting, immunoassays, RT-qPCR, RNA accessibility, uptake, target engagement, hepatotoxicity screening, complement activation, primary neurons, cardiomyocytes, iPSC-derived models, confocal and high-content imaging, CRISPR workflows.
Professional Experience
- Appointed AI Champion representing 300+ scientists in a 3,000+ person R&D organization, leading an AI Task Force that surfaces, packages, and scales AI use cases.
- Built predictive toxicity models (including TLR8) that enabled in silico discovery of novel sequences, validated in vitro, now progressing toward clinical trials.
- Designed and deployed a fully automated hit-picking platform handling multiple toxicity liabilities and efficacy readouts across therapeutic targets, reducing processing from days to minutes.
- Developed AI agents for bench-level scientists to ensure standardization and optimization across research workflows.
- Built reproducible Python workflows for assay data QC, normalization, visualization, feature engineering, and interpretable analysis across 16+ screening campaigns and 1M+ data points.
- Led automation strategy for core screening assays, including liquid-handling workflows, operator guides, and training materials.
- Collaborated across biology, automation, computational, and engineering teams to align experimental design with scalable data infrastructure.
- Conducted high-throughput safety screening of RNA therapeutics using primary cortical neurons and iPSC-derived cardiomyocyte models.
- Optimized cell culture protocols for toxicity assessments and performed high-content imaging and confocal microscopy workflows.
- Authored Python scripts for imaging data analysis, single-cell analysis, hazard scoring, statistical summaries, and visualization.
- Supported targeted sequencing workflows for transcript quantification and ASO effectiveness assessment.
- Supported clinical study report drafting and medical writing workflows in a regulated clinical development environment.
- Contributed to lean writing initiatives and collaborated with Regulatory Affairs, Biostatistics, and Clinical Research stakeholders.
- Investigated Type I interferon signaling in tumor progression, cancer stem cell plasticity, and immune-cell function.
- Performed multi-color flow cytometry, macrophage assays, tissue processing, and RNA-seq pathway analysis.
- First-author publication on interferons and cancer stem cell plasticity in Cytokine & Growth Factor Reviews.
- Supported Scientific Writing, Revelle Writing, and BENG 162 Biotechnology Laboratory courses.
- Led CRISPR-Cas9 lab instruction, discussion sections, grading, office hours, and thesis-level writing feedback.
- Prepared 1000+ manuscripts and journal submission packages across biology, life sciences, and social sciences.
- Managed journal formatting, author correspondence, quality assurance, and editorial operations.
Selected Publications, Presentations, and Writing
- Scientists must leverage, not compete with, AI systems, The Scientist, 2025.
- Interferons as therapeutic orchestrators of cancer stem cell plasticity and therapy response, Cytokine & Growth Factor Reviews, 2025.
- India's biotech surge builds momentum but faces scale bottlenecks, The Hindu, 2025.
- AI in biomanufacturing: can India policies match ambitions?, The Hindu, 2025.
- Development of a high-throughput screening strategy to assess species-specific complement activation by antisense oligonucleotides. Presented at oligonucleotide therapeutics and gene therapy forums.
- Statistical analysis of air pollution, diseases and mortality, IJRAR.
- Management and utilization of keratin waste, IJARIIT.
Selected Projects
- Created Bench to Bytes, a self-directed 12-week AI/ML course translating machine learning into molecular biology language.
- Developed collagen scaffold strategy incorporating oral mucosal epithelial cells and angiostatin for limbal stem cell deficiency concepts.
- Designed electrochemical biosensor concept for hepatocellular carcinoma detection using two lncRNA biomarkers.
- Built ready-tech automated bioreactor business model and translational commercialization plan.
Scientific Communication, Leadership, and Service
- Founder and editor of The BioTalk Magazine: 13 issues, 120+ authors, 200+ articles, 4000+ readers across a global biotechnology community.
- Chair for Breakfast with Industry, connecting UCSD bioengineering students with ~100 industry professionals.
- Founder and chair of a bio-entrepreneurship competition for biotechnology engineering students.
- Enrolled at The Leadership Edge for business certification (starting September 2026).
- AACR affiliate member, Women In Bio member, peer reviewer, and volunteer with MedTech Mentor, Young Women in Bio, Lafayette Elementary, Punarvas Foundation, Teach for India, Akanksha Foundation, Sampoorna Shiksha, and Hema Foundation.